期刊文献+

二苯甲基哌嗪类化合物结构与活性的量子化学研究 被引量:2

The Quantum Chemistry Study of the Structure and Activation of Diphenyl Methyl Piperazine
在线阅读 下载PDF
导出
摘要 为揭示标题化合物结构与活性的关系,采用量子化学AM1方法对二苯甲基哌嗪类化合物进行了量子化学计算,根据计算结果分析了12种化合物的生成热、总能量、电子能量、偶极矩、前沿轨道能级和电子结构等与其活性的关系,结果发现这类物质的结构与活性之间存在着一定的相关关系,其活性部位主要集中在苯环和杂环上,而活性的大小与取代基的种类及位置有关,吸电子能力强的基团(如—F,—NO2)的引入有利于最低空轨道能级的降低,使化合物的活性提高. To reveal the relation between the structure and activation of a compound, AM 1 method of quantum chemistry is adopted for the calculation of diphenyl methyl piperazine. According to the calculation results, the relation is analyzed between the activity and the generation heat, the total energy, the electronic energy, the orbit energy level of forward position and the electronic structure of twelve kinds of compounds. It is discovered that there exists an interrelation between the structure of these substances and the activity, whose active positions are mainly centralized at benzene ring and miscellaneous ring. The degree of the activity has much to do with the positions and the kinds that replace the methyl. The introduction of the methyl group (—F, —NO2), which holds a strong ability of inhaling electronics, will be much helpful to downgrading of the minimum empty orbit energy level and to the upgrading of the activation of a compound.
出处 《西南师范大学学报(自然科学版)》 CAS CSCD 北大核心 2003年第6期926-929,共4页 Journal of Southwest China Normal University(Natural Science Edition)
关键词 二苯甲基哌嗪 结构 活性 量子化学 AM1方法 变态反应 药物 diphenyl methyl piperazine AM1 method structure activation
  • 相关文献

参考文献6

二级参考文献9

  • 1戴岳.齐墩果酸对变态反应的抑制作用[J].中国药理学报,1988,9(6):563-563.
  • 2徐叔云.药理实验方法学,第二版[M].北京:人民卫生出版社,1994.1215,1235.
  • 3陈夏英.脑益嗪的合成[J].医药工业,1982,10:4-5.
  • 4徐叔云,药理实验方法学(第2版),1994年,714页
  • 5徐叔云,药理实验方法学(第2版),1994年,719页
  • 6王泽民,当代结构药物全集,1993年,1977页
  • 7Jo H J,Yakhak Hoechi,1990年,34卷,2期,126页
  • 8戴岳,中国药理学报,1988年,9卷,6期,562页
  • 9李光华,胡绍渝.非甾体抗炎新药联苯乙酸的合成[J].中国医药工业杂志,1991,22(6):250-251. 被引量:12

共引文献6

同被引文献32

  • 1吕仁庆,邱广敏,曹作刚,刘晨光.不同构型氨基酸甜味与其量子化学参数的相关研究[J].化学世界,2006,47(2):74-77. 被引量:4
  • 2Kimura Y, Aoki J, Kohno M, et al. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel[J]. Cancer Chemother Pharmacol, 2002, 49(4):322-328.
  • 3Gilles Klopman, Leming M, Avner Ramu. Quantitative structure-activity relationship of multidrug resistance reversal agents[J]. Mol Pharmacol, 1997, 52(2):323-334.
  • 4Naoki Sugiyama, Fumihiko Akahoshi, Shigeki Kuwahara, et al. Synthesis and topical anti-inflammatory and Antiallergic activities of Antioxidant o-Aminophenol Derivatives[J]. J Med Chem, 1994, 37(13):1977-1982.
  • 5Mass A J, Morganroth J, Cardiac effects of ebastine and other antihistiamines in humans[J]. Drug Saf, 2000, 22(3):214-216.
  • 6Brik A, Tashkin D P, Gong H Jr, et al. Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma[J]. J Allergy Clin Immunol, 1987, 80(1):51-56.
  • 7Stenphen H, Kawai Robert J, Hambalek, et al. A facile synthesis of an oxidation product of terfenadine[J]. J Med Chem, 1994, 59(9), 2620-2622.
  • 8Ciprandi G, Tosca M A, Cosentino C, et al. Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules[J]. J Allergy Clin Immunol, 2003, 112(4 Suppl): 78-82.
  • 9Salmun L M. Antihistamines in late-phase clinical development for allergic disease[J]. Expert Opin Investig Drugs, 2002, 11(2):259-273.
  • 10Fireman P, Tanner E, Choung J, et al. Effect of topical ucb-28754 on rhinitis provoked by intranasal histamine in the money[J]. Allergy Clin Immunol News, 1994, Suppl(2):1136-1139.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部